Mr Jyotindra Trivedi has more than 35 years of experience in Indian financial services industry and more than 25 years with Indian Venture Capital and Private Equity Industry. Mr Trivedi joined CDC, a UK based development finance institution, in 1997 to set up its Mumbai office. He was one the founding partners when Actis LLP was spun out of CDC in 2004. He took over leadership of Actis South Asia in 2007. Mr Trivedi retired from Actis in 2017. By 2017, Actis had raised more than US$12bn since it was formed in 2004. As a member of global investment committee of Actis Mr Trivedi had an overview of the investment activity of Actis across its key markets such as China, South Asia, Africa and Latin America and its key sectors such as Consumer, Healthcare, Financial Services and Industrial. Mr Trivedi has been involved in numerous investments of Actis in India, most notably India Infoline(IIFL), Glenmark Pharmaceuticals, UTI Bank(now Axis Bank), Sterling Hospitals, Paras Pharmaceuticals and Avtec many of which have grown into large businesses with leadership position in their respective sectors. Prior to Joining CDC, Mr Trivedi was senior vice president of GVFL, one of the first VC funds India. Mr Trivedi was part of the founding team of GVFL when it was set up in 1990 and was involved with its first three funds which focused on technology based start-up and early stage companies. Prior to joining GVFL he worked with GIIC, a development bank and Atul Products, a dyes and intermediates conglomerate. Mr Trivedi graduated as a chemical engineer from the Indian Institute of Technology, Bombay and holds a Diploma in Finance from the Institute of Chartered Financial Analysts of India. Mr Trivedi currently serves on the board of Ostro Energy Private Limited which is an Actis owned company and is building a clean energy platform with Wind and Solar assets of more than 1000mw capacity in India.

pharmaceutical science